Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback